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Abstract
Background: Common electrocardiogram (ECG) manifestations in acute pulmonary em-
bolism (APE) include ST-segment deviation (STDV) along with negative T-waves (NTW). 
STDV could occur in 3 typical ischemic patterns: (i) the left ventricular (LV) subendocardial 
ischemic pattern; (ii) the right ventricular (RV) transmural ischemic pattern; and (iii) the LV 
subendocardial plus RV transmural ischemic pattern. The purpose of this study was to evalu-
ate the relationship of STDV and adverse clinical outcomes and to identify the relationship of 
relatively normal ECG and favorable clinical outcomes.
Methods: Retrospective analysis of electronic charts in APE patients was performed in a tertiary 
hospital. ECGs on admission were obtained and classified as with or without STDV. Adverse clini-
cal outcomes were defined as need to intensify therapy and 30-day mortality. Relatively normal ECG 
was defined as without any STDV, abnormal QRS morphology in lead V1 and S1Q3T3.
Results: From a total of 210 patients with NTW, 131 had STDV ≥ 0.1 mV, while 79 did not. 
Patients with STDV had worse evolution: higher incidence of dyspnea, hypotension, cardiogen-
ic shock, intensification of therapy, and death compared to patients without STDV (p = 0.001  
for each variable). The majority (89%) of the patients with STDV presented with 1 of the  
3 typical ischemic ECG patterns. LV subendocardial ischemic pattern (OR = 4.963, p = 0.004),  
RV transmural ischemic pattern (OR = 3.128, p = 0.021) and LV subendocardial plus RV 
transmural ischemic pattern (OR = 3.036, p = 0.017) independently predicted the need to 
intensify therapy. RV transmural ischemic pattern (OR = 4.227, p = 0.031) and LV subendo-
cardial plus RV transmural ischemic pattern (OR = 4.022, p = 0.032) independently predicted 
30-day mortality. Compared to the patients with abnormal ECG, the patients with relatively 
normal ECG had a significant lower incidence of death (0% vs. 16%; p = 0.001) and need to 
intensify therapy during hospitalization (6% vs. 30%; p = 0.002).
Conclusions: Ischemic ECG patterns are common ECG manifestations of APE and predict 
worse evolution and 30-day mortality. Additionally, relatively normal ECGs may associate 
with favorable clinical outcomes. (Cardiol J 2015; 22, 5: 583–589)
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Introduction
Negative T waves (NTW) in the inferior and 
precordial leads is a recognized electrocardiogram 
(ECG) manifestation of acute pulmonary embolism 
(APE) [1, 2] and has been suggested as a marker 
of right ventricular (RV) strain (RVS) [3] or RV 
dysfunction (RVD) [4, 5].
ST-segment deviation (STDV) (elevation and/ 
/or depression) is another common ECG manifesta-
tion of APE [6–8]. STDV could occur in 3 specific 
ischemic patterns: (i) left ventricular (LV) sub-
endocardial ischemic pattern; (ii) RV transmural 
ischemic pattern; and (iii) LV subendocardial plus 
RV transmural ischemic pattern [9].
The purpose of this study was to evaluate the 
relationship of STDV and adverse clinical outcomes 
in APE patients with NTW and to investigate the 




There were 342 patients diagnosed with APE 
in our hospital from January 2008 to July 2014, 
including 315 patients confirmed by multidetec-
tor computed tomographic (MDCT) pulmonary 
angiography and 27 patients highly suspected by 
ventilation-perfusion scintigraphy. Using a retro- 
spective analysis, 210 patients with NTW were 
included in this study: 131 patients with and 
79 patients without STDV ≥ 0.1 mV (Fig. 1).
The inclusion criteria were: (i) acute onset 
of clinical signs and symptoms before admission 
suggesting APE; (ii) APE confirmed by MDCT 
pulmonary angiography; and (iii) admission ECG 
with NTW ≥ 0.1 mV in at least 2 leads out of the 
inferior (II, III and aVF) and V1–V4 leads.
The exclusion criteria were: (i) history of 
chronic heart failure or confirmed pulmonary hy-
pertension associated with other cardiopulmonary 
disease (chronic obstructive pulmonary disease 
was not excluded if there was no confirmed history 
of pulmonary hypertension by echocardiogram); 
(ii) concomitant cardiac disease possibly causing 
NTW in the inferior or precordial leads, such as 
acute coronary syndrome, hypertrophic cardiomyo-
pathy or tako-tsubo cardiomyopathy confirmed by 
coronary and/or LV angiography; (iii) ECG mani-
festation of complete left branch bundle block, LV 
hypertrophy or ventricular pacing.
The study was approved by the Shiyan Taihe 
Hospital bioethical committee.
Electrocardiogram
After admission, an ECG using a paper speed 
of 25 mm/s with standardization of 1 mV/10 mm 
was recorded. Both ST-segment elevation (STE) 
and ST-segment depression (STD) were measured 
at the J-point in all leads and were considered pre-
sent if the J-point was ≥ 0.1 mV above or below the 
isoelectric line. The LV subendocardial ischemic 
pattern was defined as STE in lead aVR with con-
comitant STD in leads V4/V5 to V6 (Fig. 2A). The 
RV transmural ischemic pattern was defined as STE 
in at least 2 leads of the leads V1 to V3 (Fig. 2B). 
The LV subendocardial plus RV transmural is-
chemic pattern was defined as STE in leads III and/ 
/or V1/V2 with concomitant STD in leads V4/V5 
to V6 (Fig. 2C). The other abnormal ECG criteria 
associated with APE are identical to our previous 
study [9]. Relatively normal ECG was defined as an 
ECG without any STDV, abnormal QRS morphol-
ogy in lead V1 (notched S wave, right bundle branch 
block [RBBB] or QR sign) and S1Q3T3. Abnormal 
ECG was defined as the presence of at least one of 
the STDV, abnormal QRS morphology in lead V1 
and S1Q3T3. Patients were categorized into two 
groups (with or without STDV) based on the ECG 
Figure 1. Flow chart of patient selection with acute pul-
monary embolism; LBBB — left bundle branch block.
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findings. All ECGs were evaluated separately by 
2 independent investigators without knowledge 
of the patients’ clinical condition. Disagreement 
between the 2 investigators was resolved by con-
sensus.
Adverse clinical outcomes
The following adverse clinical outcomes were 
recorded: need to intensify therapy based on the 
Management Strategies and Prognosis in Pulmo-
nary Embolism Trial-3 (MAPPET-3) study criteria 
[10], including cardiac arrest, need for inotropic 
support, mechanical ventilation for respiratory sup-
port and treatment with thrombolysis or surgical 
embolectomy; and 30-day mortality.
Statistical analysis
All data were analyzed by SPSS 12.0. Data were 
expressed as mean ± standard deviation for continu-
ous variables and rates (%) for categorical variables. 
The Student’s U test was used for comparison of 
continuous variables. Categorical variables were 
compared using the c2 test or the Fisher exact test. 
All ECG variables were analyzed by multivariate 
logistic regression to identify predictors of the need 
to intensify therapy and 30-day mortality. Odds ra-
tios (ORs) and 95% confidence intervals (CIs) were 
calculated. A 2-tailed probability value < 0.05 was 
considered statistically significant.
Results
Among the 210 patients, 185 (88%) patients 
presented with NTW in at least 1 inferior and 
1 precordial lead. Of the 131 patients with STDV, 
frequent findings were STE in leads V1 (47%), V2 
(31%), III (28%) and aVR (68%) and STD in leads I 
(60%), and V4/V5–V6 (60%). There were 24 (18%) 
patients with the LV subendocardial ischemic pat-
tern, 41 (31%) patients with the RV transmural 
ischemic pattern, and 52 (40%) with the LV sub-
endocardial plus RV transmural ischemic pattern. 
The remaining 14 (11%) patients did not meet the 
criteria of the pre-specified three ischemic ECG pat-
terns. The distribution of STDV is listed in Table 1.
The two groups were not statistically different 
with regard to gender, age, clinical symptoms of 
hemoptysis, chest discomfort, cough or syncope. 
Figure 2. Examples of the ischemic electrocardiographic patterns. A. Left ventricular (LV) subendocardial ischemic 
pattern; B. Right ventricular (RV) transmural ischemic pattern; C. LV plus RV ischemic pattern.
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Comparing to patients without STDV, patients with 
STDV had a shorter time from symptom onset to 
admission (6.6 ± 3.2 vs. 9.2 ± 4.8 day, p = 0.004); 
lower systolic (117 ± 29 vs. 130 ± 25 mm Hg, 
p = 0.001) and diastolic blood pressure (74 ± 22 
vs. 81 ± 14 mm Hg, p = 0.004); higher incidence 
of dyspnea on exertion (84% vs. 65%, p = 0.001) 
and at rest (45% vs. 22%, p = 0.001); hypotension 
(17% vs. 0%, p = 0.001); cardiogenic shock (27% 
vs. 5%, p = 0.001); death (18% vs. 5%, p = 0.006); 
and the need to intensify therapy (35% vs. 11%, 
p = 0.001). Demographic and clinical data are listed 
in Table 2.
The multivariate logistic regression analysis 
of the ECG parameters for the prediction of 30-day 
mortality and the need to intensify therapy dur-
ing hospitalization are listed in Table 3. We found 
that the LV subendocardial ischemic pattern (OR 
= 4.963, p = 0.004), the RV transmural ischemic 
pattern (OR = 3.128, p = 0.021) and the LV sub-
endocardial plus RV transmural ischemic pattern 
(OR = 3.036, p = 0.017) independently predicted 
the need to intensify therapy during hospitalization. 
In addition, the RV transmural ischemic pattern 
(OR = 4.227, p = 0.031) and the LV subendocardial 
plus RV transmural ischemic pattern (OR = 4.022, 
p = 0.032) independently predicted 30-day mortality.
Of the 36 patients fulfilling the criteria of 
relatively normal ECG on admission, there were 
2 patients needing to intensify therapy and no 
death. Accordingly, compared to the patients with 
abnormal ECG, the patients with relatively normal 
ECG had a significant lower incidence of death (0% 
vs. 16%, p = 0.001) and need to intensify therapy 
during hospitalization (6% vs. 30%, p = 0.002).
Table 2. Demographic and clinical data. 
APE patients with  
ST deviation (n = 131)
APE patients without  
ST deviation (n = 79)
P
Gender (male/female) 55/76 37/42 NS
Age [years] 59 ± 14 56 ± 15 NS
Time from symptom onset to admission [day] 6.6 ± 3.2 9.2 ± 4.8 0.004
Heart rate [bpm] 110 ± 23 95 ± 23 < 0.001
Systolic BP [mm Hg] 117 ± 29 130 ± 25 0.001
Diastolic BP [mm Hg] 74 ± 22 81 ± 14 0.004
Symptoms on admission:
Hemoptysis 8 (6%) 7 (9%) NS
Dyspnea on exertion 110 (84%) 51 (65%) 0.001
Dyspnea on rest 59 (45%) 17 (22%) 0.001
Chest discomfort 51 (39%) 30 (38%) NS
Cough 26 (20%) 19 (24%) NS
Syncope 38 (29%) 19 (24%) NS
Hypotension 22 (17%) 0 (0%) 0.001
Cardiogenic shock 36 (27%) 4 (5%) 0.001
30-day death 24 (18%) 4 (5%) 0.006
Need to intensify therapy 46 (35%) 9 (11%) 0.001
Data are expressed as mean ± standard deviation for continuous variables and as number (%) or ratio for categorical variables; APE — acute 
pulmonary embolism; BP — blood pressure; NS — not significant
Table 1. Distribution of ST-segment deviation in 
patients with ST-segment deviation (n = 131).
STE in V1 ≥ 0.1 mV 61 (47%)
STE in V2 ≥ 0.1 mV 41 (31%)
STE in V3 ≥ 0.1 mV 11 (8%)
STE in III ≥ 0.1 mV 37 (28%)
STE in III and aVF ≥ 0.1 mV 14 (11%)
STE in aVR ≥ 0.1 mV 89 (68%)
STD in I ≥ 0.1 mV 78 (60%)
STD in V4/V5–V6 ≥ 0.1 mV 78 (60%)
LV subendocardial ischemic pattern 24 (18%)
RV transmural ischemic pattern 41 (31%)
LV plus RV transmural ischemia pattern 52 (40%)
LV — left ventricle; RV — right ventricle; STE — ST-segment eleva-
tion; STD — ST-segment depression
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Discussion
STDV is considered a common, but non-
-specific, ECG manifestation in patients with APE 
by some authors [11, 12]. However, the literature 
suggests that the distribution of STDV has consist-
ent regularity and mechanisms [6–9, 13–16]. STE 
in leads V1, III, aVR and STD in leads I and V4/
V5–V6 are frequently observed in APE [6, 7, 9]. 
In our study, the most common STDV were also 
STE in leads V1, V2, III and aVR and STD in leads 
I and V4/V5–V6.
We have described that 3 distinct ischemic ECG 
patterns represent different manifestations of RV 
and LV transmural and subendocardial ischemia [9]. 
According to our results, these ECG patterns are 
frequent (89%) in APE patients with STDV and 
NTW. The mechanism of the ischemic patters has 
been attributed to hypotension, hypoxemia, pul-
monary artery hypertension, and catecholamine 
surge [9, 14].
In this study, we have demonstrated that STDV 
with concomitant NTW had worse evolution com-
pared to NTW without STDV. Patients with STDV 
had a higher incidence of dyspnea on exertion or 
on rest, hypotension, cardiogenic shock, need to 
intensify the therapy, and higher 30-day mortality 
compared to patients without STDV. The 3 distinct 
ischemic ECG patterns could be used to identify 
patients at higher risk of worse clinical adverse 
outcomes. To our knowledge, we are the first to 
demonstrate that the relatively normal ECGs (no 
STDV, absence of notched S wave or RBBB or QR 
sign in lead V1 and S1Q3T3) are associated with 
favorable clinical outcomes. It should be pointed 
out that the relatively normal ECG still present 
with NTW ≥ 0.1 mV in at least 2 leads out of the 
inferior (II, III and aVF) and V1–V4 leads.
NTW in the inferior and precordial leads has 
been suggested as a marker of RVS [3] or RVD 
[4, 5]. However, another study [17] suggested 
that an increase in the amplitude of NTW in the 
precordial leads after thrombolytic therapy reflects 
an improvement in cardiopulmonary hemodynam-
ics with concomitant decrease of both RV diameter 
and mean pulmonary artery pressure. We previ-
ously described the dynamic ECG changes in 
2 patients and found that NTW developed later than 
STE and that the NTW persisted beyond recovery 
of RVD [14]. In another study [9], none of the 
8 patients with acquired APE during hospitalization 
presented with NTW in precordial leads during 
hypotension or cardiogenic shock; additionally, all 
8 patients showed STE and/or STD. Hence, NTW 
in the inferior and precordial leads without STDV 
might represent a “post-ischemic” ECG stage, 
thus reflecting a previous, transient, stage of RV 
stretch and ischemia [9, 14]. We also speculate 
Table 3. Multivariate logistic regression analysis of electrocardiogram (ECG) parameters for the  
prediction of 30-day mortality and the need to intensify therapy during hospitalization.
ECG parameter 30-day death  
(n = 28)
P Need to intensify  
therapy (n = 55)
P 
OR CI OR CI
Atrial fibrillation/atrial flutter 1.360 0.386–4.795 NS 1.022 0.354–2.946 NS
S1Q3T3 3.169 0.988–10.169 0.052 1.792 0.787–4.082 NS
Left axis deviation 1.266 0.435–3.683 NS 0.566 0.233–1.372 NS
Right axis deviation 1.022 0.340–3.072 NS 1.061 0.441–2.553 NS
Low QRS voltage 1.633 0.429–6.219 NS 1.003 0.36–3.086 NS
Clockwise rotation 0.287 0.052–1.584 NS 0.532 0.162–1.746 NS
Notched S wave in V1 1.225 0.397–3.778 NS 1.535 0.599–3.938 NS
RBBB in V1 0.643 0.162–2.549 NS 0.916 0.329–2.553 NS
Qr sign in V1 0.778 0.239–2.530 NS 1.036 0.413–2.598 NS
Number of leads with negative T waves 1.181 0.960–1.454 NS 1.098 0.928–1.299 NS
LV subendocardial ischemic pattern 3.711 0.781–17.628 NS 4.963 1.668–14.768 0.004
RV transmural ischemic pattern 4.227 1.144–15.625 0.031 3.128 1.190–8.225 0.021
LV plus RV transmural ischemia pattern 4.022 1.130–14.319 0.032 3.036 1.219–7.562 0.017
CI — confidence interval; LV — left ventricle; NS — not significant; OR — odds ratio; RBBB — right bundle branch block; RV — right ventricle 
www.cardiologyjournal.org 587
Zhong-Qun Zhan et al., Significance of ST-segment deviation in acute pulmonary embolism
that more leads with NTW reflect more extensive 
prior ischemia. Hence, there is a conflicting rela-
tionship between NTW and RVD or the severity of 
the APE in the literature. Association of NTW and 
RVD or the severity of the APE can be found in 
patients with STDV [14] and in patients who were 
not treated for APE [3, 5]. More leads with NTW 
are also related to worse short-term prognosis 
[18, 19]. However, there is a poor relationship in 
patients after effective treatment where the RVD 
has possibly been recovered [14, 17].
The following are commonalities between the 
findings of our groups’ studies and the studies by 
the Kukla’s group [6, 7, 19]. First, STDV reflects 
worse prognosis compared to NTW. Second, STE in 
leads V1, III and aVR and STD in leads V4/V5–V6 
and NTW in the inferior and precordial leads are 
common ECG manifestations of APE. However, the 
differences between our study and Kukla’s group 
are obvious. We identified three types of ischemic 
ECG patterns that are common ECG manifesta-
tions and of prognostic significance. Kukla et al. 
[7] found that “global ischemic pattern” (presence 
of at least one lead with STE in leads III, aVR and 
V1–V4 and at least two leads with STD in I, aVL 
and V4–V6) similar to our LV subendocardial plus 
RV transmural ischemic pattern was not associated 
with worse outcome in intermediate-risk APE pa-
tients. However, “ST-segment ischemic pattern” 
(presence of at least one lead with STE in leads III, 
aVR and V1–V4 or at least two leads with STD in 
leads I, aVL and V4–V6) is associated with a worse 
prognosis in intermediate-risk APE patients. We 
suggest that this difference is mainly attributed to 
having a lower incidence of global ischemic pattern 
than that of ST-segment ischemic pattern (13.9% 
vs. 44.5%) in intermediate-risk APE patients. Inci-
dentally, the LV subendocardial plus RV transmural 
ischemic pattern is the main ECG presentation 
(80%) in the high-risk APE patients [9] and signi-
fies worse adverse clinical outcomes in this study. 
According to Kukla et al. [19], the mortality rate 
was significantly higher in patients with NTW in 
the inferior and precordial leads compared to the 
group without NTW. In addition, as compared to 
those with NTW in < 5 leads, patients with NTW 
≥ 5 leads experienced significantly higher rates of 
death and complications. We did not find the num-
ber of leads with NTW to be associated with worse 
adverse clinical outcomes. This phenomenon may 
be attributed to a smaller number of patients in our 
study (210 vs. 470 patients) and methodological dif-
ferences — we used the number of leads with NTW, 
while Kukla et al. [19] used a cut-off of 5 leads in 
their analyses. In addition, our group used J-point 
as the measuring point of STDV while the Kukla’s 
group used 80 ms after the J-point; this may ac-
count for further discrepancy between our studies.
Limitations of the study
Our study has several limitations. It is a retro-
spective single center study. Different departments 
and different physicians may have variable criteria 
with regards to need to intensify therapy. There 
are many factors influencing STDV and we could 
not rule out all the confounding factors such as 
concomitant coronary artery disease or paradoxical 
coronary embolism.
Conclusions
Ischemic ECG patterns are common ECG 
manifestations of APE. They are clinically im-
portant as they could predict adverse clinical 
outcomes. Prompt recognition of these patterns 
may help in avoiding inaccurate diagnosis leading 
to unnecessary medical investigations and treat-
ments and may aid in detecting high-risk patients 
with APE. Relatively normal ECGs may associate 
with favorable clinical outcomes.
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